Sign inJoin waitlistJoin the waitlist

RH

Robert Hermann

Specialist

Credentials: ·

History

Hematology and Medical Oncology
Internal Medicine

Research

TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer
Journal of Clinical Oncology · 2005 · 1,174 citations
Cetuximab and first-line taxane/carboplatin chemotherapy in advanced non-small-cell lung cancer: results of the randomized multicenter phase III trial BMS099
Journal of Clinical Oncology · 2010 · 345 citations
PointBreak: a randomized phase III study of pemetrexed plus carboplatin and bevacizumab followed by maintenance pemetrexed and bevacizumab versus paclitaxel plus carboplatin and…
Journal of Clinical Oncology · 2013 · 306 citations

CR
Craig Reynolds
3 papers
DS
David Spigel
3 papers
Edward Garon
3 papers
FG
Frank Greco
3 papers
JH
John Hainsworth
3 papers
Jyoti Patel
3 papers
Mark Olsen
3 papers
MS
Mark Socinski
3 papers
Philip Bonomi
3 papers
Ramaswamy Govindan
3 papers
SD
Shaker Dakhil
3 papers
SG
Susan Guba
3 papers